Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rallybio (RLYB) Long-Term Investments (2023 - 2025)

Rallybio (RLYB) has disclosed Long-Term Investments for 3 consecutive years, with $626000.0 as the latest value for Q2 2025.

  • Quarterly Long-Term Investments rose 10.21% to $626000.0 in Q2 2025 from the year-ago period, while the trailing twelve-month figure was $626000.0 through Jun 2025, up 10.21% year-over-year, with the annual reading at $239000.0 for FY2023, N/A changed from the prior year.
  • Long-Term Investments hit $626000.0 in Q2 2025 for Rallybio, up from $413000.0 in the prior quarter.
  • In the past five years, Long-Term Investments ranged from a high of $626000.0 in Q2 2025 to a low of $102000.0 in Q3 2023.
  • Historically, Long-Term Investments has averaged $362500.0 across 3 years, with a median of $358500.0 in 2024.
  • Biggest five-year swings in Long-Term Investments: surged 322.55% in 2024 and later rose 10.21% in 2025.
  • Year by year, Long-Term Investments stood at $239000.0 in 2023, then surged by 80.33% to $431000.0 in 2024, then skyrocketed by 45.24% to $626000.0 in 2025.
  • Business Quant data shows Long-Term Investments for RLYB at $626000.0 in Q2 2025, $413000.0 in Q1 2025, and $431000.0 in Q3 2024.